BIOLASE Inc. (BIOL) Price to Earnings Ratio

Corporate emblem and logo of BIOLASE Inc. (BIOL)

The price visualization on the GURU.Markets platform highlights the success of BIOLASE, Inc. (BIOL) in partnering with medical universities to implement laser techniques. The business relies on the comprehensive supply of systems, ancillary products, and digital courses, which minimizes regional threats. The current metric stands at -0.10, while development depends on the pace of clinic upgrades, requiring the management of marketing expenses alongside a stable cash reserve.

Biolase Inc. (BIOL) Price to Earnings Ratio: for the period 07/04/2022 - 08/04/2024

Comprehensive metric breakdowns and analytics for Biolase, Inc. (BIOL)

- price and consensus price forecast:
Stock Price biolase.com|BIOL - Price Target Chart
- market capitalization details:
Market Value BIOLASE, Inc.|BIOL - Enterprise Value
- book capitalization information:
Net Assets per Share BIOLASE|BIOL - Company Net Assets|Market Capitalization to Net Assets biolase.com|BIOL - Company Total Assets
- debt and solvency information:
Debt to Capital BIOLASE, Inc.|BIOL - Long-Term Debt to Capital|Short-Term Debt to Capital Ratio Biolase Inc.|BIOL - Company Total Debt|Debt to Net Assets Ratio BIOLASE, Inc.|BIOL - Company Long-Term Debt|Company Current Liabilities BIOLASE|Immediate Liquidity biolase.com
- earnings and market multiples details:
BIOL - Net Profit|Net Profit Forecast BIOLASE, Inc.|BIOL - P/E Multiple|Market Cap to Projected Earnings BIOLASE Inc.|BIOL - PEG Multiple|Enterprise Value to EBITDA Ratio BIOLASE, Inc.|BIOL - Operating profit EBITDA|Net earnings per share (EPS TTM) BIOLASE|BIOL - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last twelve months biolase.com|BIOL - Net earnings per share growth this year|Expected earnings per share trend next year BIOLASE, Inc.
General company analysis:biolase.com - BIOL
Original product of biolase.com

The P/E ratio reflects the market value of a single unit of net income, determining the investment payback period. By analyzing the price-to-earnings trend of BIOLASE, Inc. (BIOL), an investor assesses the capitalization efficiency of revenues generated from the sale of patented laser systems. The strong pricing power of BIOLASE, Inc. (BIOL) and the inelastic demand for Waterlase support the fundamental stability of earnings. A decline in this metric may indicate that the asset is undervalued, while a rising multiple confirms market confidence in the issuer's technological advantage.

Analysis of competing companies

P/E Multiple bostonscientific.com|Price to Earnings Ratio Edwards Lifesciences Corporation (EW)|Price to Earnings Ratio RMD (ResMed Inc)|P/E Multiple PODD (OmniPod)|Business Payback Period Zimmer Biomet (ZBH)|COO: Price to Earnings Ratio|Market Cap to Net Income ALGN|GMED: P/E Multiple|Market Cap to Earnings TransMedics Organ Care System (TMDX)|ATEC (ATEC Spine) - P/E Multiple|Price to Earnings Multiple AORT (Artivion Corp)|Price to Earnings Ratio ENOV (Enovis Corporation)|IART (integralife.com) - Company Value to Net Income|Price to Earnings Ratio Establishment Labs Holdings Inc. ESTA|BBNX - Price to Earnings Ratio|Iradimed - P/E Multiple|Market Cap to Earnings Embecta Health|TNDM: P/E Multiple|Price to Earnings Multiple AXGN|SIBN (SI-BONE) - P/E Multiple|Orthofix Medical (OFIX) - Business Payback Period|P/E Multiple BVS|Price to Earnings Ratio orthopediatrics.com KIDS|P/E Multiple TMCI (Treace Medical Concepts)|P/E Multiple blade.com SRTA|CARL - Price to Earnings Ratio|RXST: Price to Earnings Ratio|CLPT (clearpointneuro.com) - Price to Earnings Ratio|Stereotaxis Corporation - Company Value to Net Income|STIM (Neuronetics, Inc.) - P/E Multiple|Market Cap to Earnings sightsciences.com SGHT|Price to Earnings Ratio Orchestra BioMed, Inc. (OBIO)|anikatherapeutics.com (ANIK) - Market Cap to Net Income Ratio|InspireMD Corp - Price to Earnings Ratio|P/E Multiple Jin Medical International Ltd. ZJYL|Vivani - P/E Multiple|Business Payback Period Xtant Medical Holdings XTNT|NeuroOne Medical Technologies Corporation (NMTC) - Price to Earnings Ratio|Market Cap to Net Income MODD (Modular Medical, Inc.)|Price to Earnings Ratio Myomo, Inc|Price to Earnings Ratio Envoy Medical Inc (COCH)|P/E Multiple VVOS|NVNO - Market Cap to Earnings|Price to Earnings Ratio Sintx Technologies, Inc. SINT|TNON: Price to Earnings Multiple|LFWD: Price to Earnings Ratio|Autonomix Medical, Inc. - Market Price to Net Income Ratio|IVF: P/E Multiple|BBLG (bonebiologics.com) - Price to Earnings Ratio|AXNX (Axonics) - P/E Multiple|Dynatronics Corp. (DYNT) - Business Payback Period|Price to Earnings Ratio Paragon 28, Inc. (FNA)|INVO - Market Cap to Earnings